Health45
Wellness Through
Investment
Health45 is a private health and wellness investment across two scalable ventures targeting a 45% fixed return over 3 years.
- Sectors
- Digital Health
- & Wellness
- Status
- Active
- Founded
- 2025
Two Ventures: One Vision
for Scalable Health Growth
Weight Loss
Investment
A fast-growing UK e-pharmacy delivering GLP-1 treatments via a scalable telehealth model, addressing access gaps and capturing strong recurring demand across an underserved market.
Nutraceutical
Investment
Proprietary, science-backed nutraceuticals driving high-margin growth, increasing customer lifetime value, and building a long-term wellness ecosystem across European markets.
3-Year Health45
Bond
A capital-secured health and wellness investment offering a fixed 45% return over three years, providing structured exposure to high-growth health ventures.
return
Private Health and Wellness Investment
Health45 captures the growth opportunity between rising global demand for GLP-1 treatments and scalable, accessible wellness solutions structured for defined investor returns.
The global obesity and wellness market is one of the fastest-growing sectors in healthcare. GLP-1 treatments alone are projected to become a multi-billion pound market in the UK over the next five years, driven by clinical effectiveness, NHS prescription growth, and surging private demand through digital health platforms. Health45 enters at the most scalable point — a UK e-pharmacy with an established telehealth delivery model and a proprietary nutraceutical range built for recurring purchase. Both ventures operate in high-margin, high-demand categories with strong visibility on revenue growth. According to the NHS Business Services Authority, GLP-1 prescriptions in England have grown significantly year on year, underpinning the commercial case for scalable digital access platforms.
Asset-Backed
Exposure
Structured exposure to two high-growth health and wellness ventures, secured against underlying business performance and aligned with revenue generation and value creation milestones.
Defined 3-Year
Timeline
A clear investment horizon aligned with business scaling, product expansion, and strategic growth milestones across the GLP-1 and nutraceutical markets.
Fixed Return
Structure
A 45% fixed return over 3 years, supported by disciplined execution, recurring revenue generation, and defined exit pathways within a controlled investment framework.
ESG-Aligned
Outcomes
Investment supports improved access to clinically backed obesity care and preventive wellness solutions, contributing to better health outcomes and long-term healthcare system sustainability.
Understanding Health45
01
Who is eligible to invest in Health45?
This opportunity is available strictly to individuals who qualify as High Net Worth or Self-Certified Sophisticated Investors under UK Financial Conduct Authority regulations. You will be asked to confirm your status before proceeding.
For other structured investment opportunities, explore Film50 and Solar45.
02
What does Health45 invest in?
03
What returns can I expect?
Investors can access a fixed return of 45% over 3 years, depending on the chosen investment route and terms. This is a private health and wellness investment structured for qualified investors. Past performance is not indicative of future results. Capital is at risk.
Contact us to discuss eligibility and access.
04
Who manages Health45?
Health45 is led by experienced professionals with backgrounds in private equity, healthcare innovation, and compliance, ensuring each venture is managed with precision and strategic foresight.
Health45 sits within the broader Univere Investment Solutions portfolio of structured investment products.
Insights from Health45
Perspectives on structuring, risk, and capital allocation across institutional markets.
- Baloico, Solar45
What the Hormuz Closure Reveals About Energy Infrastructure
- Solar45
The Evolution of Energy Infrastructure Investment at Scale
Register Your Interest
Related Projects
Selected projects aligned with Health45’s development strategy and value creation model.
